[Safety evaluation of simultaneous administration of quadrivalent influenza split virion vaccine and 23-valent pneumococcal polysaccharide vaccine in adults aged 60 years and older].

Zhu, Z K; Lu, X; Tang, W Q; Sun, J W; Shen, L; Chen, Q L; Liu, H X; Yu, Y; Gu, W; Zhao, Y W; Xie, Y

Zhu, Z K; Lu, X; Tang, W Q; Sun, J W; Shen, L; Chen, Q L; Liu, H X; Yu, Y; Gu, W; Zhao, Y W; Xie, Y.

Afiliação

Zhu ZK; Taizhou Center for Disease Control and Prevention, Taizhou 225300, China.
Lu X; Sinovac Biotech Co., Ltd., Beijing 100085, China.
Tang WQ; Taizhou Center for Disease Control and Prevention, Taizhou 225300, China.
Sun JW; Sinovac Life Sciences Co., Ltd., Beijing 102601, China.
Shen L; Taizhou Center for Disease Control and Prevention, Taizhou 225300, China.
Chen QL; Sinovac Biotech Co., Ltd., Beijing 100085, China.
Liu HX; Taizhou Center for Disease Control and Prevention, Taizhou 225300, China.
Yu Y; Taizhou Center for Disease Control and Prevention, Taizhou 225300, China.
Gu W; Taizhou Center for Disease Control and Prevention, Taizhou 225300, China.
Zhao YW; Sinovac Life Sciences Co., Ltd., Beijing 102601, China.
Xie Y; Taizhou Center for Disease Control and Prevention, Taizhou 225300, China.

Zhonghua Yu Fang Yi Xue Za Zhi ; 57(9): 1412-1417, 2023 Sep 06.

Article em Zh | MEDLINE | ID: mdl-37554083

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google